Company News
-
LifeTech Announces 2017 Interim ResultsLifeTech Scientific Corporation, the leading supplier of minimally invasive interventional medical devices to treat cardiovascular diseases and its subsidiaries announces its comprehensive financial results as of June 30, 2017 .2017 / 08 / 25
-
LifeTech announced the launch of its global post-market surveillance study for LAmbre ? LAA Closure SystemOn June 30, at the Congenital and Structural Intervention Congress (CSI) 2017 in Frankfurt, LifeTech Scientific Corporation (Stock Code: 1302.HK) announced the launch of a 3-year global post-market surveillance (PMS) study for the LAmbreTM Left Atrial Appendage (LAA) Closure System. The study planned to enroll more than 500 patients from about 30 clinical centers in Europe, Asia and South America.2017 / 07 / 03
-
LifeTech Announces 2016 Annual ResultsDomestic Market Consolidation and Global Channel Expansion,Diversified Innovative Portfolio Promoted Sustainable Development,Steady Growth of Revenue and Significant Rise of Profitability.2017 / 03 / 25
